209 related articles for article (PubMed ID: 31953350)
1. Recurrence patterns in patients with abnormal cardiophrenic lymph nodes at ovarian cancer diagnosis.
Larish A; Mert I; McGree M; Weaver A; Sheedy S; Cilby W
Int J Gynecol Cancer; 2020 Apr; 30(4):504-508. PubMed ID: 31953350
[TBL] [Abstract][Full Text] [Related]
2. Cardiophrenic lymph node resection in cytoreduction for primary advanced or recurrent epithelial ovarian carcinoma: a cohort study.
Lopes A; Rangel Costa RL; di Paula R; Anton C; Calheiros Y; Sartorelli V; Kanashiro YM; de Lima JA; Yamada A; Pinto GLS; Vianna MR; Nogueira Dias Genta ML; Ribeiro U; Dos Santos MO
Int J Gynecol Cancer; 2019 Jan; 29(1):188-194. PubMed ID: 30640703
[TBL] [Abstract][Full Text] [Related]
3. Surgical management of cardiophrenic lymph nodes in patients with advanced ovarian cancer.
Prader S; Harter P; Grimm C; Traut A; Waltering KU; Alesina PF; Heikaus S; Ataseven B; Heitz F; Schneider S; du Bois A
Gynecol Oncol; 2016 May; 141(2):271-275. PubMed ID: 26972337
[TBL] [Abstract][Full Text] [Related]
4. What are the implications of radiologically abnormal cardiophrenic lymph nodes in advanced ovarian cancer? An analysis of tumour burden, surgical complexity, same-site recurrence and overall survival.
Addley S; Asher V; Kirke R; Bali A; Abdul S; Phillips A
Eur J Surg Oncol; 2022 Dec; 48(12):2531-2538. PubMed ID: 35718677
[TBL] [Abstract][Full Text] [Related]
5. Feasibility, safety and clinical outcomes of cardiophrenic lymph node resection in advanced ovarian cancer.
Cowan RA; Tseng J; Murthy V; Srivastava R; Long Roche KC; Zivanovic O; Gardner GJ; Chi DS; Park BJ; Sonoda Y
Gynecol Oncol; 2017 Nov; 147(2):262-266. PubMed ID: 28888540
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of enlarged cardiophrenic lymph nodes in advanced ovarian cancer: Implications for survival.
Mert I; Kumar A; Sheedy SP; Weaver AL; McGree ME; Kim B; Cliby WA
Gynecol Oncol; 2018 Jan; 148(1):68-73. PubMed ID: 29129390
[TBL] [Abstract][Full Text] [Related]
7. Preoperative Prediction of Cardiophrenic Lymph Node Metastasis in Advanced Ovarian Cancer Using Computed Tomography.
Kim TH; Lim MC; Kim SI; Seo SS; Kim SH; Park SY
Ann Surg Oncol; 2016 Apr; 23(4):1302-8. PubMed ID: 26714941
[TBL] [Abstract][Full Text] [Related]
8. Enlarged cardiophrenic lymph nodes predict disease involvement of the upper abdomen and the outcome of primary surgical debulking in advanced ovarian cancer.
Luger AK; Steinkohl F; Aigner F; Jaschke W; Marth C; Zeimet AG; Reimer D
Acta Obstet Gynecol Scand; 2020 Aug; 99(8):1092-1099. PubMed ID: 32112653
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic value of selective lymphadenectomy in interval debulking surgery for stage IIIc and IV epithelial ovarian cancer.
Song N; Gao Y
Int J Gynecol Cancer; 2019 May; 29(4):761-767. PubMed ID: 30850437
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors and the role of primary debulking in operable stage IVB ovarian cancer with supraclavicular lymph node metastasis: a retrospective study in Chinese patients.
Quan C; Chen X; Wen H; Wu X; Li J
BMC Cancer; 2024 May; 24(1):565. PubMed ID: 38711015
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for lymph node metastasis in apparent early-stage epithelial ovarian cancer: implications for surgical staging.
Powless CA; Aletti GD; Bakkum-Gamez JN; Cliby WA
Gynecol Oncol; 2011 Sep; 122(3):536-40. PubMed ID: 21636114
[TBL] [Abstract][Full Text] [Related]
12. FDG PET/CT in staging of advanced epithelial ovarian cancer: frequency of supradiaphragmatic lymph node metastasis challenges the traditional pattern of disease spread.
Hynninen J; Auranen A; Carpén O; Dean K; Seppänen M; Kemppainen J; Lavonius M; Lisinen I; Virtanen J; Grénman S
Gynecol Oncol; 2012 Jul; 126(1):64-8. PubMed ID: 22542580
[TBL] [Abstract][Full Text] [Related]
13. Prognostic role of mesenteric lymph nodes involvement in patients undergoing posterior pelvic exenteration during radical or supra-radical surgery for advanced ovarian cancer.
Berretta R; Capozzi VA; Sozzi G; Volpi L; Ceni V; Melpignano M; Giordano G; Marchesi F; Monica M; Di Serio M; Riccò M; Ceccaroni M
Arch Gynecol Obstet; 2018 Apr; 297(4):997-1004. PubMed ID: 29380107
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of supradiaphragmatic lymphadenopathy identified on preoperative computed tomography scan in patients undergoing primary cytoreduction for advanced epithelial ovarian cancer.
Kolev V; Mironov S; Mironov O; Ishill N; Moskowitz CS; Gardner GJ; Levine DA; Hricak H; Barakat RR; Chi DS
Int J Gynecol Cancer; 2010 Aug; 20(6):979-84. PubMed ID: 20683405
[TBL] [Abstract][Full Text] [Related]
15. Is there any therapeutic role of pelvic and para-aortic lymphadenectomy in apparent early stage epithelial ovarian cancer?
Bizzarri N; du Bois A; Fruscio R; De Felice F; De Iaco P; Casarin J; Vizza E; Chiantera V; Corrado G; Cianci S; Magni S; Ferrari D; Giuliani D; Harter P; Ataseven B; Bommert M; Perrone AM; Scambia G; Fagotti A
Gynecol Oncol; 2021 Jan; 160(1):56-63. PubMed ID: 33168305
[TBL] [Abstract][Full Text] [Related]
16. What can we learn from the 10 mm lymph node size cut-off on the CT in advanced ovarian cancer at the time of interval debulking surgery?
Benoit L; Zerbib J; Koual M; Nguyen-Xuan HT; Delanoy N; Le Frère-Belda MA; Bentivegna E; Bats AS; Fournier L; Azaïs H
Gynecol Oncol; 2021 Sep; 162(3):667-673. PubMed ID: 34217542
[TBL] [Abstract][Full Text] [Related]
17. Pattern and impact of metastatic cardiophrenic lymph nodes in advanced epithelial ovarian cancer.
Prader S; Vollmar N; du Bois A; Heitz F; Schneider S; Ataseven B; Bommert M; Waltering KU; Heikaus S; Koch JA; Alesina PF; Traut A; Harter P
Gynecol Oncol; 2019 Jan; 152(1):76-81. PubMed ID: 30463683
[TBL] [Abstract][Full Text] [Related]
18. Recurrence patterns after bevacizumab in platinum-sensitive, recurrent epithelial ovarian cancer.
Kim SI; Lee EJ; Lee M; Chung H; Kim JW; Park NH; Song YS; Kim HS
Int J Gynecol Cancer; 2020 Dec; 30(12):1943-1950. PubMed ID: 33055266
[TBL] [Abstract][Full Text] [Related]
19. Cardiophrenic lymph nodes in liver transplant candidates with hepatocellular carcinoma: imaging characteristics and post-transplant outcomes.
Lee C; Kim A; Santos I; Cen Y; Alexopoulos S; Navarro S; Wallman M; Dhanireddy K; Grant E
Clin Transplant; 2014 Dec; 28(12):1402-9. PubMed ID: 25284352
[TBL] [Abstract][Full Text] [Related]
20. Subtypes of stage IV ovarian cancer; response to treatment and patterns of disease recurrence.
Jamieson A; Sykes P; Eva L; Bergzoll C; Simcock B
Gynecol Oncol; 2017 Aug; 146(2):273-278. PubMed ID: 28549816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]